The Breast Cancer Monitoring Marker
CA 15-3 is a protein shed from breast cancer cells into the blood. It's not sensitive enough for screening or early detection (normal in most early-stage breast cancers), but it's valuable for monitoring metastatic breast cancer treatment response and detecting recurrence.
What is CA 15-3?
CA 15-3 is a mucin glycoprotein (MUC1 gene product) expressed on breast epithelium and shed into blood. Normal: <30 U/mL. Elevated in ~70% of metastatic breast cancer but only ~20% of early stage. Primary use: monitoring metastatic breast cancer.
↑ What High CA 15-3 Means
In the context of known breast cancer: suggests disease progression or recurrence. Can also be elevated in lung, ovarian, and pancreatic cancers, and in benign conditions like liver disease, endometriosis, and breast fibroadenomas.
Common symptoms:
CA 15-3 itself causes no symptoms · Breast cancer symptoms: lump, skin changes, nipple discharge · Metastatic: bone pain, shortness of breath, jaundice depending on site
↓ What Low CA 15-3 Means
Reassuring in breast cancer monitoring context. Doesn't exclude early-stage disease.
Common symptoms:
No symptoms
Why It Matters
When normal:
Monitors metastatic breast cancer treatment response
Detects recurrence (may rise before clinical/imaging evidence)
Prognostic marker in metastatic disease
Risks if abnormal:
Not useful for screening or early detection
Can be elevated in benign conditions
Initial rise after starting treatment may be "flare" (not progression)
What Can Cause Abnormal Levels?
Metastatic Breast Cancer
40% likelyElevated in ~70% of metastatic breast cancer. Correlates with tumor burden.
Benign Breast/Liver Conditions
30% likelyFibroadenomas, liver disease, endometriosis can mildly elevate.
Other Cancers
Ovarian, lung, pancreatic cancers.
Autoimmune Disease
SLE and rheumatoid arthritis.
What You Can Do
CA 15-3 is a monitoring tool for known breast cancer, not a screening test
Impact: Don't use for breast cancer screening—mammography is the standard \u00B7 Timeline: N/A
If lifestyle changes aren't enough:
Beware of "tumor marker flare" after starting chemotherapy
Impact: Initial CA 15-3 rise may indicate tumor kill, not progression \u00B7 Timeline: 4-8 weeks
Recommended retest: Per oncology protocol for metastatic disease monitoring
Related Markers
Got your blood test report?
Upload your PDF and understand ALL your markers in 2 minutes. Plain language. Traffic light status. No medical jargon.
Analyze My Report — FreeFirst report is free. No credit card needed.